Riskpilot← Back to searchSign inGet full accessMinerva Medica AB
ABActiveOrg 5569672826Kålsängsgränd 10 D 3 TrMedical specialists activities · NACE 8622Est. 201450-99 employees
Revenue 2024
SEK 60,7M
+30% vs 2023
EBITDA margin
-27.7%
+1% vs 2023
Equity ratio
42.3%
Financial strength
Net profit 2024
SEK -17M
| Revenue | SEK 60,7M | +30% |
| EBITDA | SEK -16,8M | +1% |
| Net profit | SEK -17M | — |
| Total assets | SEK 20,4M | -40% |
| Equity | SEK 8,6M | -63% |
| Employees | — | — |
Legal name
Minerva Medica AB
Org number
5569672826
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 april 2014
Share capital
SEK 50 000
Employees
50-99
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Verksamheten bedriver vård, medicinsk utveckling och forskning med fokus på gynekologi och kvinnohälsa samt sjukvård, forskning och utbildning med inriktning på reproduktionsmedicin.
Address
Kålsängsgränd 10 D 3 Tr
Email
kristina.torn@cmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 16 767 | 36 119 | 36 764 | 46 606 | 60 704 |
| Staff expenses | — | — | −17 645 | −30 533 | −37 937 |
| EBITDA | 2 688 | 10 433 | −547 | −16 967 | −16 830 |
| Depreciation & amort. | −440 | −1 658 | −1 564 | −2 546 | −2 720 |
| EBIT | 2 248 | 8 775 | −2 111 | −19 513 | −19 550 |
| Net financials | 1 | 1 | 94 | −824 | 350 |
| Profit before tax | 1 341 | 9 265 | −7 | 18 | −17 032 |
| Tax | −1 048 | −1 913 | — | −18 | −6 |
| Net profit | 293 | 7 352 | −7 | 0 | −17 038 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 203 | 18 983 | 13 849 | 33 752 | 20 412 |
| Equity | 7 789 | 11 141 | 7 433 | 23 433 | 8 628 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 5 852 | 5 261 | 5 822 | 8 151 | 11 785 |
| Total debt | 5 852 | 5 261 | 5 822 | 8 151 | 11 785 |
EBITDA margin
-27.7%
This company
15.8%
Market median
-275% vs market
20202024
Equity ratio
42.3%
This company
38.2%
Market median
+11% vs market
20202024
Return on equity
-197.5%
This company
18.4%
Market median
-1173% vs market
20202024
Net profit margin
-28.1%
This company
8.1%
Market median
-447% vs market
20202024
Asset turnover
2.97×
This company
1.12×
Market median
+165% vs market
20202024
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KK Chief Auditor | Chief Auditor | 2022 |
AM Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
AM Audit | Audit | 2021 – 2022 |
BE External Signatory | External Signatory | 2021 – 2022 |
JP Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (10) | ||
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2024 – 2025 | |
| Chairman | 2022 – 2022 | |
| Chairman | 2023 – 2024 | |
| Chairman | 2023 – 2023 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2022 – 2023 | |
| Board of Directors | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C-MEDICAL GROUP AS
Minerva Medica AB Board members of Minerva Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Marie Svedare | Audit | 0 companies |
| Björn Erik Olander | External Signatory | 0 companies |
| Jan Peter Mikael Åkerud | Deputy Chief Executive Officer | 0 companies |
| Karin Kristina Eriksson | Chief Auditor | 0 companies |
| Anna Maria Kristina Törn | Chief Executive Officer | 0 companies |
| Linda Maria Axebäck | Board of Directors | 0 companies |
| Houtan Houshangi | Board of Directors | 0 companies |
| Thomas Haugen Skorpen | Board of Directors | 0 companies |
| Øyvind Bakke | Board of Directors | 0 companies |
| Martin Sture Fagerlund | Chairman | 0 companies |
| Gard Lauvsnes | Board of Directors | 0 companies |
| Madeleine Engen | Chairman | 0 companies |
| Lisa Helena Alin | Chairman | 0 companies |
| Patrik Bø Egeland | Chairman | 0 companies |
| Anna Ulrika Hansson | Board of Directors | 0 companies |
| Åsa Helena Åkerud Larsson | Chairman | 0 companies |
| Madeleine Engen | Board of Directors | 0 companies |